Clinical trials
Phase 3 Myasthenia Gravis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 9 |
| 2022 | 5 |
| 2023 | 5 |
| 2024 | 9 |
| 2025 | 6 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Recruiting | 15 |
| Active, not recruiting | 11 |
| Terminated | 5 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| UCB Biopharma SRL | 11 |
| Alexion Pharmaceuticals, Inc. | 9 |
| argenx | 7 |
| Astellas Pharma Inc | 3 |
| Catalyst Pharmaceuticals, Inc. | 2 |
| First Affiliated Hospital, Sun Yat-Sen University | 2 |
| Harbour BioMed (Guangzhou) Co. Ltd. | 2 |
| Hoffmann-La Roche | 2 |
| Immunovant Sciences GmbH | 2 |
| Janssen Research & Development, LLC | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myasthenia Gravis | 67 |
| Autoimmune Diseases | 2 |
| Muscle Weakness | 1 |
| Thymoma | 1 |
Trials
Showing 26 to 50 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.